TY - JOUR
T1 - Allopregnanolone does not influence ethanol-induced conditioned place preference in DBA/2J mice
AU - Gabriel, Kara I.
AU - Cunningham, Christopher L.
AU - Finn, Deborah A.
PY - 2004/10/1
Y1 - 2004/10/1
N2 - Rationale: The neurosteroid allopregnanolone (ALLOP; 3α-hydroxy- 5α-pregnan-20-one) produces behavioral and discriminative characteristics similar to that of ethanol (EtOH) and can modulate some of the behavioral and electrophysiological effects of EtOH. Objective: The present experiments investigated ALLOP modulation of the effects of EtOH in a place conditioning procedure in male DBA/2J mice. Methods: In a series of experiments examining different EtOH doses (1, 2 g/kg) and ALLOP administration times, ALLOP (0, 3.2, 10, 17 mg/kg, IP) was administered four times with EtOH prior to placement on a distinctive floor (CS+). On alternate days, vehicle was administered prior to a saline injection paired with the other floor stimulus (CS-). In a separate experiment, finasteride (0, 50, 100 mg/kg, IP), a 5α-reductase inhibitor that blocks ALLOP synthesis, was administered prior to both CS+ and CS- trials. In a final experiment, animals were place conditioned to EtOH alone, and ALLOP (0, 3.2, 10, 17 mg/kg, IP) was administered prior to the preference test only. Results: During conditioning, ALLOP increased and finasteride decreased EtOH-stimulated activity compared with vehicle pretreatment. Acquisition of 2 g/kg EtOH-induced conditioned place preference was observed in all mice, regardless of treatment with either ALLOP or finasteride. Similarly, ALLOP did not modulate the expression of EtOH-induced place preference. EtOH increased brain ALLOP levels compared with saline; however, ALLOP administration produced dose-dependent elevations in brain ALLOP levels that were not further augmented by EtOH (2 g/kg) administration. Conclusions: These findings indicate that ALLOP does not modulate EtOH-induced place conditioning in male DBA/2J mice.
AB - Rationale: The neurosteroid allopregnanolone (ALLOP; 3α-hydroxy- 5α-pregnan-20-one) produces behavioral and discriminative characteristics similar to that of ethanol (EtOH) and can modulate some of the behavioral and electrophysiological effects of EtOH. Objective: The present experiments investigated ALLOP modulation of the effects of EtOH in a place conditioning procedure in male DBA/2J mice. Methods: In a series of experiments examining different EtOH doses (1, 2 g/kg) and ALLOP administration times, ALLOP (0, 3.2, 10, 17 mg/kg, IP) was administered four times with EtOH prior to placement on a distinctive floor (CS+). On alternate days, vehicle was administered prior to a saline injection paired with the other floor stimulus (CS-). In a separate experiment, finasteride (0, 50, 100 mg/kg, IP), a 5α-reductase inhibitor that blocks ALLOP synthesis, was administered prior to both CS+ and CS- trials. In a final experiment, animals were place conditioned to EtOH alone, and ALLOP (0, 3.2, 10, 17 mg/kg, IP) was administered prior to the preference test only. Results: During conditioning, ALLOP increased and finasteride decreased EtOH-stimulated activity compared with vehicle pretreatment. Acquisition of 2 g/kg EtOH-induced conditioned place preference was observed in all mice, regardless of treatment with either ALLOP or finasteride. Similarly, ALLOP did not modulate the expression of EtOH-induced place preference. EtOH increased brain ALLOP levels compared with saline; however, ALLOP administration produced dose-dependent elevations in brain ALLOP levels that were not further augmented by EtOH (2 g/kg) administration. Conclusions: These findings indicate that ALLOP does not modulate EtOH-induced place conditioning in male DBA/2J mice.
KW - Allopregnanolone
KW - DBA/2J
KW - Ethanol
KW - Locomotor activity
KW - Place conditioning
UR - http://www.scopus.com/inward/record.url?scp=3142585854&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3142585854&partnerID=8YFLogxK
U2 - 10.1007/s00213-004-1862-2
DO - 10.1007/s00213-004-1862-2
M3 - Article
C2 - 15083256
AN - SCOPUS:3142585854
VL - 176
SP - 50
EP - 56
JO - Psychopharmacology
JF - Psychopharmacology
SN - 0033-3158
IS - 1
ER -